Shenzhen Zhenrui Biotech Co.,Ltd – Trademark Portfolio
Entity Type: 99
Shenzhen Zhenrui Biotech Co.,Ltd has 6 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 6 are successfully registered — a 100% registration rate. The portfolio includes marks such as CHINREAL. Filings span 3 Nice Classification classes, with the highest activity in Class 1 (Chemicals) and Class 10 (Medical Apparatus). This trademark owner is based in Shenzhen, Guangdong.
501, Building B, 1# Qingning Road
Longhua Street, Longhua District
Shenzhen, Guangdong 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shenzhen Zhenrui Biotech Co.,Ltd's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Shenzhen Zhenrui Biotech Co.,Ltd have?
Shenzhen Zhenrui Biotech Co.,Ltd has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does Shenzhen Zhenrui Biotech Co.,Ltd file in?
Shenzhen Zhenrui Biotech Co.,Ltd files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Shenzhen Zhenrui Biotech Co.,Ltd's most well-known trademarks?
Shenzhen Zhenrui Biotech Co.,Ltd's registered trademark portfolio includes well-known marks such as CHINREAL. These are among 6 currently registered trademarks in the portfolio.
What is Shenzhen Zhenrui Biotech Co.,Ltd's trademark registration success rate?
Shenzhen Zhenrui Biotech Co.,Ltd has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.